Loading…
Loading grant details…
| Funder | Swedish Research Council |
|---|---|
| Recipient Organization | Karolinska Institutet |
| Country | Sweden |
| Start Date | Dec 01, 2023 |
| End Date | Nov 30, 2026 |
| Duration | 1,095 days |
| Number of Grantees | 7 |
| Roles | Co-Investigator; Principal Investigator |
| Data Source | Swedish Research Council |
| Grant ID | 2023-01949_VR |
Suicide is the leading cause of death for ages 10-19-years in Sweden. The most reliable predictor of suicide is self-harm (including suicide attempts).
Decades of research have failed to produce reliable assessments of risk factors for self-harm that could be applied with confidence in the clinic. Further, few evidence-based out-patient treatments for self-harm exist to date.
Instead, involuntary care is increasingly used in this population, despite evidence indicating that it may worsen prognosis. Two studies will be conducted.
Study 1 aims to identify clinically applicable risk factors of self-harm and Study 2 is a randomized clinical trial for youth who self-harm.
Study 1 will for the first time assess youth at risk of self-harm prospectively (aged 12 to 14-years) at two timepoints: pre onset of self-harm and at follow-up.
Participants will be assessed using a range of psychophysiological, cognitive, and psychosocial measures, with a particular focus on pain-sensitivity.
Identified individuals with self-harm will be included in a parallel randomized controlled trial (total N=200) of a cognitive behavioral family treatment targeting risk factors for self-harm and suicide, compared to an active control group.
By identifying clinically applicable risk factors and evaluating a potentially effective out-patient intervention, this project aims to reduce the need for involuntary care and prevent suicide in youth.
Karolinska Institutet
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant